Sionna Therapeutics, Inc. (SION) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Sionna Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -21.84x | -17.88x | -23.34x | -27.41x |
| P/B Ratio | 5.36x | -6.74x | -9.60x | -15.78x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||
| Current Ratio | 20.61x | 14.49x | 4.88x | 10.16x |
| Quick Ratio | 20.61x | 14.49x | 4.88x | 10.16x |
| Leverage | ||||
| Debt/Equity | 0.03x | -0.06x | -0.09x | 0.00x |
YoY = year-over-year change. Source: FMP..